High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level
Authors
Keywords
Survivin, Breast cancer, Prognosis
Journal
Breast Cancer
Volume 21, Issue 4, Pages 482-490
Publisher
Springer Nature
Online
2012-09-11
DOI
10.1007/s12282-012-0403-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Invasive Breast Cancer
- (2017) Robert W. Carlson et al. Journal of the National Comprehensive Cancer Network
- Review: In women 39 to 69 years of age, screening with mammography reduces breast cancer mortality
- (2013) Laura Rees Willett ANNALS OF INTERNAL MEDICINE
- Innovative biomarker development for personalized medicine in breast cancer care
- (2011) George C Zografos et al. Biomarkers in Medicine
- Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin
- (2011) Ronan J Kelly et al. Molecular Cancer
- Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer
- (2010) Elton Rexhepaj et al. BMC CANCER
- Comparison of mRNA and Protein Measures of Cytokines following Vaccination with Human Papillomavirus-16 L1 Virus-like Particles
- (2010) F. M. Shebl et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Survivin as a global target of intrinsic tumor suppression networks
- (2010) Minakshi Guha et al. CELL CYCLE
- Acetylation Directs Survivin Nuclear Localization to Repress STAT3 Oncogenic Activity
- (2010) Haijuan Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Insulin-like Growth Factor Receptor 1 (IGF1R) Gene Copy Number Is Associated With Survival in Operable Non–Small-Cell Lung Cancer: A Comparison Between IGF1R Fluorescent In Situ Hybridization, Protein Expression, and mRNA Expression
- (2010) Rafal Dziadziuszko et al. JOURNAL OF CLINICAL ONCOLOGY
- A risk stratification by hormonal receptors (ER, PgR) and HER-2 status in small (≤1 cm) invasive breast cancer: who might be possible candidates for adjuvant treatment?
- (2009) Yeon Hee Park et al. BREAST CANCER RESEARCH AND TREATMENT
- The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti-HER-2 Therapy and Personalized Medicine
- (2009) J. S. Ross et al. ONCOLOGIST
- Survivin and Caspase-3 Expression in Breast Cancer: Correlation With Prognostic Parameters, Proliferation, Angiogenesis, and Outcome
- (2009) Aziza Nassar et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Identification of biomarkers in ductal carcinoma in situ of the breast with microinvasion
- (2008) Yasuhiro Okumura et al. BMC CANCER
- Advances in Breast Cancer: Pathways to Personalized Medicine
- (2008) O. I. Olopade et al. CLINICAL CANCER RESEARCH
- The use of genomic tools for the molecular understanding of breast cancer and to guide personalized medicine
- (2008) J FOEKENS et al. DRUG DISCOVERY TODAY
- The expression of BIRC5 is correlated with loss of specific chromosomal regions in breast carcinomas
- (2008) Romain Boidot et al. GENES CHROMOSOMES & CANCER
- New wirings in the survivin networks
- (2008) D C Altieri ONCOGENE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started